DVM
BIVV

Dreman Value Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Dreman Value Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10
Closed -$1K – 460
2017
Q4 		$1K Sell
10
-290
-97% -$15.9K ﹤0.01% 448
2017
Q3 		$17K Buy
+300
New +$17.6K 0.01% 333

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Dreman Value Management's BIVV Position: Q1 2018 in Review

Dreman Value Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 10 shares — an estimated $1K sold.

Dreman Value Management first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $17K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Dreman Value Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Dreman Value Management sold 10 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1K.
  • Dreman Value Management first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Dreman Value Management's Bioverativ Inc. Common Stock position peaked at $17K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.